These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Influence of salt intake on the antihypertensive effect of carvedilol. Ruilope LM; Lahera V J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238 [TBL] [Abstract][Full Text] [Related]
23. Comparison of carvedilol and atenolol for angina pectoris. Freedman SB; Jamal SM; Harris PJ; Kelly DT Am J Cardiol; 1987 Sep; 60(7):499-502. PubMed ID: 2888302 [TBL] [Abstract][Full Text] [Related]
24. Intractable recurrent ventricular tachycardia in dilated cardiomyopathy controlled by a vasodilating beta blocker. Wright DJ; Cooke GA; Tan LB Heart; 1997 Jun; 77(6):581-2. PubMed ID: 9227309 [No Abstract] [Full Text] [Related]
25. Effects of carvedilol on ventricular arrhythmias. Senior R; Müller-Beckmann B; DasGupta P; van der Does R; Lahiri A J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S117-21. PubMed ID: 1378137 [TBL] [Abstract][Full Text] [Related]
26. Angina, ischemia, and effort tolerance with vasodilating beta-blockers. Dargie HJ; Grant S; McLenachan J Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726 [TBL] [Abstract][Full Text] [Related]
28. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease. Matsuda Y; Akita H; Terashima M; Shiga N; Kanazawa K; Yokoyama M Am Heart J; 2000 Nov; 140(5):753-9. PubMed ID: 11054621 [TBL] [Abstract][Full Text] [Related]
29. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris]. Lai C; Tallu B; Onnis E; Pirisi R; Cioglia G; Cherchi A Cardiologia; 1984 Dec; 29(12):605-14. PubMed ID: 6152549 [No Abstract] [Full Text] [Related]
30. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker. DiNicolantonio JJ; Hackam DG Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523 [TBL] [Abstract][Full Text] [Related]
32. Are there differences between vasodilating and nonvasodilating beta-blockers in patients with heart failure? Do patients with ischemic heart disease benefit to the same degree? Dickerson LM; Carek PJ J Fam Pract; 2000 Jun; 49(6):496, 571. PubMed ID: 10923546 [No Abstract] [Full Text] [Related]
33. Carvedilol: therapeutic application and practice guidelines. Bleske BE; Gilbert EM; Munger MA Pharmacotherapy; 1998; 18(4):729-37. PubMed ID: 9692647 [TBL] [Abstract][Full Text] [Related]
34. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy. Horenstein MS; Ross RD; Singh TP; Epstein ML Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497 [TBL] [Abstract][Full Text] [Related]
35. Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies. Szwed H; Hradec J; Préda I Coron Artery Dis; 2001 Feb; 12 Suppl 1():S25-8. PubMed ID: 11286304 [TBL] [Abstract][Full Text] [Related]
36. Carvedilol inhibits aortic lipid deposition in the hypercholesterolemic rat. Feuerstein GZ; Fisher M; Nunnart J; Ruffolo RR Pharmacology; 1997 Jan; 54(1):24-32. PubMed ID: 9065958 [TBL] [Abstract][Full Text] [Related]
37. A new molecule with vasodilating and beta-adrenoceptor blocking properties. Abshagen U J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364 [TBL] [Abstract][Full Text] [Related]
38. Carvedilol--A new nonselective beta blocker. Forrest E; Stanley A; Hayes P Hepatology; 2000 Mar; 31(3):809-11. PubMed ID: 10722317 [No Abstract] [Full Text] [Related]
39. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure. DasGupta P; Broadhurst P; Lahiri A J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973 [TBL] [Abstract][Full Text] [Related]